Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Takara Bio to develop gene therapy for non-Hodgkin's lymphoma

Nov. 2, 2011

European orphan drug status for Celldex Therapeutics' rindopepimut

Nov. 2, 2011

CytRx reports further on phase Ib/II study of INNO-206

Nov. 2, 2011

Galena Biopharma focuses on late-stage targeted cancer drug development

Nov. 2, 2011

Sanofi presents new Met inhibitors

Nov. 2, 2011

Circadian Technologies clear to start clinical development of VGX-100

Nov. 2, 2011

Natural plant-derived product inhibits proliferation of gastric cancer cells

Nov. 2, 2011

BerGenBio begins preclinical development of lead product

Oct. 31, 2011

New phase Ib/II study of BEZ-235 launched

Oct. 31, 2011

Acceleron Pharma begins phase II trial of ACE-041 in head and neck cancer

Oct. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...